Summary
We have previously shown that disulfiram (DSF) blocks the urotoxicity of cyclophosphamide (CYT) in mice and increases the oncolytic effect of CYT in the L1210 murine leukemia. However, mice treated with CYT and DSF appeared to have longer-lasting neutropenia than animals treated with CYT alone. To determine whether DSF uroprotection of CYT-treated mice was associated with increased myeloid toxicity, we examined the effects of DSF plus CYT treatment on the bone marrow granulocyte/macrophage progenitor cell (GM-CFC). Marrow cellularity and GM-CFC numbers were analyzed at 1, 2 and 3 days after injection of CYT (62.5 or 125 mg/kg) or CYT plus DSF (200 mg/kg). CYT alone caused a decrease in total marrow cellularity varying from 20% to 50% of control. Animals given CYT plus DSF had a somewhat greater decrease in total marrow cellularity than those treated with CYT alone. However, in mice treated with CYT plus DSF, the GM-CFC were relatively well preserved and the recovery of the GM-CFC was not prolonged by DSF. It appears from these studies that the acute toxic effect of CYT on the granulocyte/macrophage progenitor cells is not enhanced by DSF.
Similar content being viewed by others
References
Berrigan MH, Marinello AJ, Pavelic Z, et al (1983) Protective role of thiols in cyclophosphamide induced urotoxicity and depression of hepatic drug metabolism. Cancer Res 42:3688
Blume KG, Bentler E, Bross KJ, et al (1980) Bone marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 302:1041
Bradley TR, Metcalf D (1960) The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 44:298
Brock N, Stekar J, Pohl J, Niemeyer U, Scheffer G (1979) Acrolein, the causative factor of urotoxic effects of cyclophosphamide, ifosfamide, trofosfamide and sulfosfamide. Arzneimittelforsch 29:659
Bryant BM, Ford HT, Tarman M, et al (1980) Prevention of isophosphamide-induced urothelial toxicity with 2-mercapthoethane sulphonate sodium (mesna) in patients with advanced carcinoma. Lancet 2:657
Ershler WB, Hacker MP, Newman RA, Stewart JA, Gamelli RL, Krakoff IH (1984) Effect of disulfiram (tetraethylthiuram disulfide) on cyclophosphamide toxicity: A clinical trial (Letter to the Editor) Cancer Treat Rep 67:1145
Faiman MD, Dodd DE, Hanzlik RE (1978) Distribution of S35 disulfiram and metabolites in mice and metabolism of S35 disulfiram in dogs. Res Commun Chem Pathol Pharmacol 21: 543
Gamelli RL, Foster RS Jr (1979) Effect of ureteral ligation and nephrectomy on granulocyte-macrophage progenitor cells and azathioprine toxicity. Transplantation 28:183
Hacker MP, Newman RA, Ershler WB (1982) The prevention of cyclophosphamide-induced cystitis in mice by disulfiram. Res Commun Chem Pathol Pharmacol 145:54
Hacker MP, Ershler WB, Newman RA, Gamelli RL (1983) Effect of disulfiram (tetrahylthiuram disulfide) and diethyldithiocarbonate on the bladder toxicity and antitumor activity of cyclophosphamide in mice. Cancer Res 42:4490
Slavik M, Saiers JH (1983) Phase I clinical study of acetylcysteine's preventing itosfamide-induced hematurea. Sem Oncol 10 [Suppl]:65
Watson NA, Notley RG (1973) Urologic complications of cyclophosphamide. Br J Urol 45:606
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gamelli, R.L., Ershler, W.B., Hacker, M.P. et al. The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity. Cancer Chemother. Pharmacol. 16, 153–155 (1986). https://doi.org/10.1007/BF00256166
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256166